Allegheny Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
46,701
+1,354
+3% +$35.4K 0.12% 101
2026
Q1
$1.27M Buy
45,347
+559
+1% +$14.9K 0.17% 85
2025
Q4
$1.12M Buy
44,788
+680
+2% +$17.1K 0.17% 90
2025
Q3
$1.12M Sell
44,108
-1,541
-3% -$38K 0.21% 85
2025
Q2
$1.11M Buy
45,649
+1,653
+4% +$38.5K 0.25% 77
2025
Q1
$1.11M Sell
43,996
-133
-0.3% -$3.48K 0.29% 66
2024
Q4
$1.17M Buy
44,129
+2,692
+6% +$73K 0.3% 62
2024
Q3
$1.2M Buy
41,437
+3,403
+9% +$99.3K 0.3% 69
2024
Q2
$1.06M Buy
38,034
+497
+1% +$13.7K 0.31% 63
2024
Q1
$1.04M Buy
37,537
+1,897
+5% +$52.6K 0.32% 58
2023
Q4
$1.03M Buy
35,640
+2,898
+9% +$87.6K 0.33% 56
2023
Q3
$1.09M Buy
32,742
+4,609
+16% +$163K 0.41% 46
2023
Q2
$1.03M Sell
28,133
-3,429
-11% -$133K 0.49% 36
2023
Q1
$1.29M Buy
31,562
+31
+0.1% +$1.34K 0.52% 35
2022
Q4
$1.62M Sell
31,531
-41
-0.1% -$1.97K 0.68% 30
2022
Q3
$1.38M Buy
31,572
+1,730
+6% +$84.1K 0.65% 27
2022
Q2
$1.56M Buy
29,842
+471
+2% +$24K 0.73% 28
2022
Q1
$1.52M Sell
29,371
-134
-0.5% -$6.95K 0.64% 33
2021
Q4
$1.74M Buy
29,505
+692
+2% +$34.3K 0.7% 31
2021
Q3
$1.24M Sell
28,813
-95
-0.3% -$4.21K 0.57% 35
2021
Q2
$1.13M Buy
+28,908
New +$1.12M 0.51% 36
2021
Q1
Sell
-30,136
Closed -$1.11M 110
2020
Q4
$1.11M Buy
+30,136
New +$1.11M 0.6% 32

Other funds holding PFE

Allegheny Financial Group's PFE Position: Q2 2026 in Review

Allegheny Financial Group increased its Pfizer (PFE) stake by 3% in Q2 2026, buying an estimated $35.4K and bringing the position to 46,701 shares worth $1.12M. The position accounts for 0.12% of the portfolio, ranked #101.

Allegheny Financial Group first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.74M in Q4 2021. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Allegheny Financial Group held 46,701 shares of Pfizer worth $1.12M as of Q2 2026.
  • Allegheny Financial Group bought 1,354 Pfizer shares in Q2 2026, an estimated $35.4K.
  • Pfizer made up 0.12% of Allegheny Financial Group's portfolio in Q2 2026, its #101 holding.
  • Allegheny Financial Group first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • Allegheny Financial Group's Pfizer position peaked at $1.74M in Q4 2021.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Allegheny Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.